您当前所在位置:首页 > 资讯信息 > 新品上市
序号 标题 次数 作者 发布时间
201871 离子液体[HOOCMMIm]Br修饰金属有机框架UiO-66-NH2|[HOOCMMIm]Br@UiO-66-NH2|齐岳生物定制 951 axc 2022-09-01
201872 聚两性离子液体(PVIPS)功能化聚吡咯/氧化石墨烯(PVIPS/PPy/GO)|齐岳生物供应环境温度离子液体 901 axc 2022-09-01
201873 ​咪唑型的离子液体(氯化1-十六烷基-3-甲基咪唑,LIL16)修饰聚甲基丙烯酸甲酯(PMMA)微球(qiyuebio) 521 axc 2022-09-01
201874 功能化离子液体(APIm)2ZnBr2负载MIL-101(MIL-101-(APIm)2ZnBr2)|离子液体的应用介绍 502 axc 2022-09-01
201875 DSPE-PEG-HAIYPRH,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-转铁蛋白靶向肽,磷脂-PEG-HAIYPRH转铁蛋白靶向肽 434 zhn 2022-09-01
201876 DSPE-PEG-THRPPMWSPVWP,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-转铁蛋白靶向肽,磷脂-PEG-转铁蛋白靶向肽 425 zhn 2022-09-01
201877 DSPE-PEG-SP94,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-肝靶向肽,DSPE-PEG-SFSHHTPILPLC 多肽 589 zhn 2022-09-01
201878 DSPE-PEG-OTC,磷脂-PEG-奥曲肽,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-生长抑索受体靶向肽 508 zhn 2022-09-01
201879 DSPE-PEG-TH,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-PH响应性细胞穿膜肽,磷脂-PEG-PH响应性细胞穿膜肽TH 448 zhn 2022-09-01
201880 NGR介导*新生血管靶向脂质材料 NGR Mediated Tumor Angiogensis Targeting Lipid Materials 496 zhn 2022-09-01
201881 APRPG介导*新生血管靶向脂质材料 APRPG Mediated Tumor Angiogensis Targeting Lipid Materials 520 zhn 2022-09-01
201882 EGFR靶向脂质材料 GE11 Mediated EGFR Targeting Lipid Materials 563 zhn 2022-09-01
201883 PTP介导胰腺*靶向脂质材料 PTP Mediated Pancreatic Carcinoma Targeting Lipid Materials 482 zhn 2022-09-01
201884 NYZL1介导膀胱靶向脂质材料 NYZL1 Mediated Bladder Cancer Targeting Lipid Materials 673 zhn 2022-09-01
201885 Sp94 Mediated Hepatocellular Carcinoma Targeting Lipid Materials,SP94介导肝*靶向脂质材料 795 zhn 2022-09-01
201886 Tumor Targeting Functional Phospholipid Materials 靶向功能磷脂材料 390 zhn 2022-09-01
201887 DSPE-PEG-SEARYL-PF6 二硬脂酰基磷脂酰乙醇胺磷脂-聚乙二醇-PH响应性细胞穿膜肽 449 zhn 2022-09-01
201888 DSPE-PEG-SEARYL-R8,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-PH响应性细胞穿膜肽,磷脂-PEG-SEARYL-R8 461 zhn 2022-09-01
201889 DSPE-PEG-R6H4,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-PH响应性细胞穿膜肽,磷脂-PEG-R6H4细胞穿膜肽 445 zhn 2022-09-01
201890 DSPE-PEG-FSHB卵泡刺激素多肽,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-卵巢靶向肽,磷脂-peg-卵巢靶向肽 508 zhn 2022-09-01
201891 DSPE-PEG-PTP,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-胰腺靶向肽,DSPE-PEG-PTP(KTLLPTP) 461 zhn 2022-09-01
201892 DSPE-PEG-GE11(EGFR靶向肽) 二硬脂酰基磷脂酰乙醇胺-聚乙二醇-细胞表皮生长因子EGFR靶向肽 473 zhn 2022-09-01
201893 DSPE-PEG-VIP,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-血管活性肠肽,VIP-PEG-DSPE,磷脂-peg-血管活性肠肽 507 zhn 2022-09-01
201894 DSPE-PEG-NGR,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-新生血管靶向肽,DSPE-PEG-NGR(Asn-Gly-Arg),磷脂-peg-新生血管靶向肽 593 zhn 2022-09-01
201895 DSPE-PEG-RGD,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-整合素靶向肽,RGD-PEG-DSPE,磷脂-peg-多肽 450 zhn 2022-09-01
201896 DSPE-PEG-cRGD(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-整合素靶向环肽,DSPE-PEG-cRGD(c[RGDfC] ,新生血管靶向环肽 687 zhn 2022-09-01
201897 DSPE-PEG-TAT,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-穿膜肽,DSPE-PEG-YGRKKRRQRRR,磷脂-peg-穿膜肽 479 zhn 2022-09-01
201898 FSHB介导卵巢**靶向脂质材料 FSHB Mediated Ovarian Carcinoma Targeting Lipid Materials 560 zhn 2022-09-01
201899 DSPE-PEG-SEARYL-EB1(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-PH响应性细胞穿膜肽,磷脂-peg-细胞穿膜肽) 427 zhn 2022-09-01
201900 DSPE-PEG-NYZL1,二硬脂酰基磷脂酰乙醇胺-聚乙二醇-膀胱 靶向肽,DSPE-PEG-NYZL1(Asn-Tyr-Glx-Leu) 558 zhn 2022-09-01
201901 DSPE-PEG-APRPG,二硬脂酰基磷脂酰乙醇胺-聚乙二醇- 新生血管靶向肽,DSPE-PEG-APRPG(Ala-Pro-Arg-Pro-Gly) 563 zhn 2022-09-01
201902 DSPE-PEG-YEQDPWGVKWWY 磷脂-PEG-多肽 二硬脂酰基磷脂酰乙醇胺-聚乙二醇-M2型巨噬细胞靶向肽 704 zhn 2022-09-01
201903 DSPE-PEG-YSA(YSAYPDSVPMMS),二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向蛋白,磷脂-PEG-YSA多肽的产品介绍 852 zhn 2022-09-01
201904 DSPE-PEG-F3(KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK) 二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向蛋白 磷脂-PEG-靶向多肽 748 zhn 2022-09-01
201905 DSPE-PEG-K237(HTMYYHHYQHHL)(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向蛋白,磷脂-PEG-靶向多肽) 847 zhn 2022-09-01
201906 DSPE-PEG-A7R(ATWLPPR)(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向多肽,磷脂-聚乙二醇-靶向蛋白) 597 zhn 2022-09-01
201907 DSPE-PEG-CREKA 二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向多肽,CREKA-peg-DSPE,磷脂-聚乙二醇-靶向蛋白 422 zhn 2022-09-01
201908 DSPE-PEG-TAASGVRSMH(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向多肽,磷脂-聚乙二醇-靶向蛋白) 809 zhn 2022-09-01
201909 DSPE-PEG-LTLRWVGLMS(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向多肽,磷脂-聚乙二醇-靶向蛋白) 448 zhn 2022-09-01
201910 DSPE-PEG-KAA(CKAAKNK)(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向多肽,磷脂-聚乙二醇-靶向蛋白) 590 zhn 2022-09-01
201911 DSPE-PEG-RGR(CRGRRST)(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向多肽,磷脂-聚乙二醇-靶向蛋白) 604 zhn 2022-09-01
201912 DSPE-PEG-LyP-1(CGNKRTRGC)(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向蛋白,磷脂-聚乙二醇-靶向多肽) 557 zhn 2022-09-01
201913 DSPE-PEG-F56(WHSDMEWWYLLG)(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向蛋白,磷脂-聚乙二醇-靶向多肽) 549 zhn 2022-09-01
201914 DSPE-PEG-P1(CSDSWHYWC)(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向蛋白,磷脂-聚乙二醇-靶向多肽) 595 zhn 2022-09-01
201915 DSPE-PEG-SPRPRHTLRLSL(二硬脂酰基磷脂酰乙醇胺-聚乙二醇-靶向蛋白,磷脂-聚乙二醇-多肽) 570 zhn 2022-09-01
库存查询